Do postoperative NSAIDs improve breast cancer outcomes? A Best Evidence Topic

International Journal of Surgery

Volumn 28, Issue , 2016, Pages 173-178

  Sutton, Liam ^a   McGlone, Emma ^a   Lambert, Kelly ^a  

^a KINGSTON HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Breast cancer; Non steroidal anti inflammatory; NSAID; Survival

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; ACETYLSALICYLIC ACID;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CASE CONTROL STUDY; COHORT ANALYSIS; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL PATIENT; BREAST NEOPLASMS; FEMALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE PERIOD;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POSTOPERATIVE PERIOD;

EID: 84960911108     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2016.02.086     Document Type: Article

References (20)

1. de Pedro M., Baeza S., Escudero M.T., Dierssen T., Gomez-Acebo I., Pollan M., Llorca J. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2015, 149(2):525-536.
2. Khan A., Dunning J., Parvaiz A.C., Agha R., Rosin D., Mackway-Jones K. To- wards evidence-based medicine in surgical practice: best BETs. Int. J. Surg. 2011, 9(8):585-588.
3. Garcia-Albeniz X., Chan A.T. Aspirin for the prevention of colorectal cancer. Best Pract. Res. Clin. Gastroenterol. 2011, 25(0):461-472.
4. Seshasai S.R.K., Wijesuriya S., Sivakumaran R., Nethercott S., Erqou S., Sattar N., Ray K.K. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch. Intern. Med. 2012, 172(3):209-216.
5. Rozic J.G., Chakraborty C., Lala P.K. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int. J. Cancer 2001, 93(4):497-506.
6. Singh B., Berry J.A., Shoher A., Ayers G.D., Wei C., Lucci A. COX-2 involvement in breast cancer metastasis to bone. Oncogene 2007, 26:3789-3796.
7. Hung W.C. Anti-metastatic action of non-steroidal anti-inflammatory drugs. Kaohsiung J. Med. Sci. 2008, 24:392-397.
8. Nash G.F., Turner L.F., Scully M.F., Kakkar A.K. Platelets and cancer. Lancet Oncol. 2002, 3:425-430.
9. Barnbace N.M., Holmes C.E. The platelet contribution to cancer progression. J. Thromb. Haemost. 2011, 9:237-249.
10. Bhattacharyya M., Girish G.V., Ghosh R., Chakraborty S., Sinha A.K. Acetyl salicylic acid (aspirin) improves synthesis of maspin and lowers incidence of metastasis in breast cancer patients. Cancer Sci. 2010, 101(10):2105-2109.
11. Guowei X., Liu Y.E., Gentz R., Sang Q.A., Ni J., Goldberg I.D., Shi Y.E. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc. Natl. Acad. Sci. 1999, 96(7):3700-3705.
12. Zou Z., Anisowicz A., Hendrix M.J., Thor A., Neveu M., Shen S., Rafidi K., Segtor E., Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263(5146):526-529.
13. R.E. Langley, R.H. Wilson, A. Ring, H.G. Kynaston, C.M. Murphy, D.A. Cameron, F.H. Cafferty, M.K. Parmar, Evidence for the use of aspirin as a treatment for cancer and the planned Add-Aspirin trial, [ webcite] (accessed 20.02.15.). http://www.comtecmed.com/cigi/2013/Abstracts_Text.aspx.
14. Bowers L.W., Maximo I.X.F., Brenner A.J., Beeram M., Hursting S.D., Price R.S., Tekmal R.R., Jolly C.A., deGraddenried L.A. NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. Cancer Res. 2014, 74(16):4446-4457.
15. Murray L.J., Cooper J.A., Hughes C.M., Powe D.G., Cardwell C.R. Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink. Breast Cancer Res. 2014, 16:R34.
16. Fraser D.M., Sullivan F.M., Thompson A.M., McCowan C. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br. J. Cancer 2014, 111:623-627.
17. Wernli K.J., Hampton J.M., Renthm-Dietz A., Newcomb P.A. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol. Drug Safe 2011, 20:131-137.
18. Holmes M.D., Wendy C.Y., Lisa L., Hertzmark E., Spiegelman D., Hankinson S.E. Aspirin intake and survival after breast cancer. J. Clin. Oncol. 2010, 28(9):1467-1471.
19. Blair C.K., Sweeney C., Anderson K.E., Folsom A.R. NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res. Treat. 2007, 101:191-197.
20. Barron T.I., Murphy L.M., Brown C., Bennett K., Visvanathan K., Sharp L. De novo post-diagnosis aspirin use and mortality in women with stage I-III breast cancer. Cancer Epidemiol. Biomark. Prev. 2015, 24(6):898-904.